taxifolin has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Cui, Y; Li, H; Liu, X; Luo, L; Ma, Y; Meng, W; Zeng, Z; Zong, D | 1 |
| Chen, Y; Liu, X; Luo, L; Ma, Y; Zeng, Z; Zong, D | 1 |
2 other study(ies) available for taxifolin and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Dihydroquercetin suppresses cigarette smoke induced ferroptosis in the pathogenesis of chronic obstructive pulmonary disease by activating Nrf2-mediated pathway.
Topics: Animals; Ferroptosis; Mice; NF-E2-Related Factor 2; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Quercetin; Smoke; Smoking | 2022 |
Taxifolin ameliorates cigarette smoke-induced chronic obstructive pulmonary disease via inhibiting inflammation and apoptosis.
Topics: Animals; Apoptosis; Cigarette Smoking; Humans; Inflammation; Mice; Nicotiana; Pulmonary Disease, Chronic Obstructive | 2023 |